The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...

The new plant will allow the company to execute end-to-end clinical- and commercial-stage production of its mRNA medicines.

Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.

Moderna (MRNA) stock is in focus as the company completes U.S. mRNA production network, investing $140M in Massachusetts and ...

New capabilities strengthen U.S. production, completing Moderna's domestic end-to-end mRNA manufacturing network ...

Two of the biggest political issues of the year are immigration and health care. Here’s a look at some recent fact checks of ...

Piper Sandler's 37 th Annual Healthcare Conference, on Tuesday, December 2 nd at 11:00am ET A live webcast of each of the presentation will be available under "Events and Presentations" in the ...

Federal funding cuts to vaccine research have impacted scientists nationwide — and some of those cuts hit close to home.